High resolution analysis of chromosome 3p alterations in cervical carcinoma

Cancer Research

Volumn 57, Issue 18, 1997, Pages 4082-4090

  Larson, Amy A ^a   Kern, Suzanne ^a,c   Curtiss, Shannon ^a   Gordon, Robert ^a   Cavenee, Webster K ^a,b   Hampton, Garret M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Genos Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 3P; FEMALE; GENE LOCUS; GENE LOSS; GENE MAPPING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ALLELES; CARCINOMA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CLONE CELLS; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; SEQUENCE DELETION; UTERINE CERVICAL NEOPLASMS;

EID: 0030804368     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 46: 5-27, 1996.
2. Morris, M., Tortolero-Luna, G., Malpica, A., Baker, V. V., Cook, E., Johnson, E., and Follen Mitchell, M. Cervical intraepithelial neoplasia and cervical cancer. Obstet. Gynecol. Clin. N. Am., 23: 347-410, 1996.
3. Palefsky, J. M., and Holly, E. A. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol. Biomark. Prev., 4: 415-428, 1995.
4. Saxon, P. J., Srivatsan, E. S., and Stanbridge, E. J. Introduction of human chromosome 11 via microcell mediated chromosome transfer controls tumorigenic expression of HeLa cells. EMBO J., 5: 3461-3466, 1986.
5. Oshimura, M., Kugoh, H., Koi, M., Shimizu, M., Yamada, H., Satoh, H., and Barrett, J. C. Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J. Cell. Biochem., 42: 135-142, 1990.
6. Ning, Y., Weber, J. L., Killary, A. M., Ledbetter, D. H., Smith, J. R., and Pereira, S. O. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc. Natl. Acad. Sci. USA, 88: 5635-5639, 1991.
7. Chen, T. M., Pecoraro, G., and Defendi, V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res., 53: 1167-1171, 1993.
8. Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T., and Terada, M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res., 49: 3598-3601, 1989.
9. Chung, G. T., Huang, D. P., Lo, K. W., Chan, M. K., and Wong, F. W. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res., 12: 1485-1490, 1992.
10. Jones, M. H., and Nakamura, Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7: 1631-1634, 1992.
11. Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, N., Tsuda, H., Hirohashi, S., Vissing, H., Shimizu, M., Oshimura, M., and Yokota, J. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene, 8: 1825-1832, 1993.
12. Karlsen, F., Rabbitts, P. H., Sundresan, V., and Hagmar, B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int. J. Cancer, 58: 787-792, 1994.
13. Mitra, A. B., Murty, V. V., Li, R. G., Pratap, M., Luthra, U. K., and Chaganti, R. S. Allelotype analysis of cervical carcinoma. Cancer Res., 54: 4481-4487, 1994.
14. Hampton, G. M., Larson, A. A., Baergen, R. N., Sommers, R. L., Kern, S., and Cavenee, W. K. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc. Natl. Acad. Sci. USA, 93: 6704-6709, 1996.
15. Srivatsan, E. S., Misra, B. C., Venugopalan, M., and Wilczynski, S. P. Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am. J. Hum. Genet., 49: 868-877, 1991.
16. Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewer, C., Liao, S., Busby-Earle, R. M., Williams, A. W., Steel, C. M., Bird, C. C., Stanbridge, E. J., and Evans, G. A., Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc. Natl. Acad. Sci. USA, 91: 6953-6957, 1994.
17. Bethwaite, P. B., Koreth, J., Herrington, C. S., and McGee, J. O. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical cancer. Br. J. Cancer. 71: 814-818, 1995.
18. Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B., and Klinger, H. P. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res., 56: 197-205, 1996.
19. Rader, J. S., Kamarasova, T., Huettner, P. C., Li, L., Li, Y., and Gerhard, D. S. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene, 13: 2737-2741, 1996.
20. Sreekantaiah, C., De Braekeleer, M., and Haas, O. Cytogenetic findings in cervical carcinoma: a statistical approach. Cancer Genet. Cytogenet., 53: 75-81, 1991.
21. Larson, A. A., Kern, S., Sommers, R. L., Yokota, J., Cavenee, W. K., and Hampton, G. M. Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res., 56: 1426-1431, 1996.
22. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
23. Thein, A. T., Han, X., Heyderman, E., Fox, M., Steele, S. J., and Parrington, J. M. Molecular cytogenetic analysis of five newly established cervical cancer cell lines using G banding and fluorescence in situ hybridization. Cancer Genet. Cytogenet., 91: 28-36, 1996.
24. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
25. Kern, S., and Hampton, G. M. Direct hybridization of large-insert genomic clones on high density gridded cDNA arrays. Biotechniques, 23: 120-124, 1997.
26. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res., 54: 1422-1424, 1994.
27. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Calitano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., William, I., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
28. Jones, M. H., Koi, S., Fujimoto, I., Hasumi, K., Kato, K., and Nakamura, Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer, 9: 119-123, 1994.
29. Chung, G. T., Huang, D. P., Lo, K. W., Chan, M. K., and Wong, F. W. Genetic lesion in the carcinogenesis of cervical cancer. Anticancer Res., 12: 1485-1490, 1992.
30. Solomon, E., Voss, R., Hall, V., Bodmer, W. F., Jass, J. R., Jeffreys, A. J., Lucibello, F. C., Patel, I., and Rider, S. H. Chromosome 5 allele loss in human colorectal carcinomas. Nature (Lond.), 328: 616-619, 1987.
31. MacGrogan, D., Levy, A., Bostwick, D., Wagner, M., Wells, D., and Bookstein, R. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance. Genes Chromosomes Cancer, 10: 151-159, 1994.
32. Cavenee, W. K., Dryja, T. P., Phillips, R. A., Benedict, W. F., Godbout, R., Gallie, B. L., Murphee, A. L., Strong, L. C., and White, R. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond.), 305: 779-784, 1983.
33. Popescu, N. C. Chromosome fragility and instability in human cancer. Crit. Rev. Oncog., 5: 121-140, 1994.
34. Wang, N. D., Testa, J. R., and Smith, D. I. Determination of the specificity of aphidicolin-induced breakage of the human 3p14.2 fragile site. Genomics, 17: 341-347, 1993.
35. Paradee, W., Wilke, C. M., Wang, L., Shridhar, R., Mullins, C. M., Hoge, A., Glover, T. W., and Smith, D. I. A 350-kb cosmid contig in 3p14.2 that crosses the t(3:8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics, 35: 87-93, 1996.
36. Popescu, N. C., and DiPaolo, J. A. Preferential sites for viral integration on mammalian genome. Cancer Genet. Cytogenet., 42: 157-171, 1989.
37. Rassool, F. V., Le Beau, M. M., Neilly, M. E., van Melle, E., Espinosa, R. D., and McKeithan, T. W. Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am. J. Hum. Genet., 50: 1243-1251, 1992.
38. Rassool, F. V., La Beau, M. M., Neilly, M. E., van Melle, E., Espinosa, R., and McKeithan, T. W. Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am. J. Hum. Genet., 50: 1234-1251, 1992.
39. Wagatsuma, M., Hashimoto, K., and Matsukura, T. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J. Virol., 64: 813-821, 1990.
40. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
41. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 6: 193-203, 1997.
42. Druck, T., Hadaczeck, P., Fu, T. B., Ohta, M., Siprashvili, Z. Baffa, R., Negrini, M., Kastury, K., Veronse, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Heubner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
43. Naylor, S. L., Moore, S., Garcia, D., Xiang, X., Xin, X., Mohrer, M., Reus, B., Linn, R., Stanton, V., O'Connell, P., and Leach, R. J. Mapping 638 STSs to regions of human chromosome 3. Cytogenet. Cell Genet., 72: 90-94, 1996.
44. Cawkwell, L., Bell, S. M., Lewis, F. A., Dixon, M. F., Taylor, G. R., and Quirke, P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br. J. Cancer, 67: 1262-1267, 1993.